1. 2022-RA-1198-ESGO Post hoc analysis of objective response rate by mismatch repair protein dimer loss/mutation status in patients with mismatch repair deficient endometrial cancer treated with dostarlimab. (20th October 2022) Authors: Tinker, Anna V; Sabatier, Renaud; Gravina, Adriano; Gilbert, Lucy; Brown, Jubilee; Samouëlian, Vanessa; Reade, Clare J; Mathews, Cara; Ellard, Susan; Banerjee, Susana; Barretina-Ginesta, Maria Pillar; Miller, Rowan; Leath, Charles; Pothuri, Bhavana; Duan, Tao; Han, Xinwei; Zografos, Eleftherios; ... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1443-ESGO Patient decision aids in genetic testing for women with ovarian cancer. (20th October 2022) Authors: Sobocan, Monika; Chandrasekaran, Dhivya; Sideris, Michail; Blyuss, Oleg; Miller, Rowan; Mills-Baldock, Tina; Crusz, Shanthini; Sun, Li; Evans, Olivia; Jenkins, Lucy; Ahmed, Munaza; Kumar, Ajith; Lockley, Michelle; Singh, Naveena; Faruqi, Asma; Casey, Laura; Brockbank, Elly; Phadnis, Saurabh; Trev... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 39/#452 Immune-related endpoints in patients with advanced or recurrent endometrial cancer treated with dostarlimab in the garnet study. (4th December 2022) Authors: Oaknin, Ana; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan; Pikiel, Joanna; Mirza, Mansoor; Duan, Tao; Zildjian, Sybil; Zografos, Eleftherios; Veneris, Jennife... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Diagnosis and management of breast cancer in men. Issue 3 (May 2016) Authors: Sellers, Laura; Miller, Rowan; Aggarwal, Ajay Journal: Trends in urology & men's health Issue: Volume 7:Issue 3(2016) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Diagnosis and management of penile cancer. Issue 5 (September 2016) Authors: Kane, Clare; Sellers, Laura; Miller, Rowan Journal: Trends in urology & men's health Issue: Volume 7:Issue 5(2016) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Genomic testing in high-grade serous ovarian cancer: current options and future development. Issue 3 (6th March 2023) Authors: Devlin, Michael-John; Miller, Rowan Journal: International journal of gynecological cancer Issue: Volume 33:Issue 3(2023) Page Start: 358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. O007/#456 Post-hoc analysis of objective response rate by mismatch repair protein dimer loss/mutation status in patients with mismatch repair deficient endometrial cancer treated with dostarlimab. (4th December 2022) Authors: Tinker, Anna; Sabatier, Renaud; Gravina, Adriano; Gilbert, Lucy; Brown, Jubilee; Samouëlian, Vanessa; Reade, Clare; Mathews, Cara; Ellard, Susan; Banerjee, Susana; Barretina-Ginesta, Maria Pilar; Miller, Rowan; Iii, Charles Leath; Pothuri, Bhavana; Duan, Tao; Han, Xinwei; Zografos, Eleftherios; V... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Outcome of patients with solid tumours admitted to intensive care. Issue 11 (November 2016) Authors: Stewart, Sarah; Hopwood, Miriam; Miller, Rowan; Ana, Pericao; Shiu, Kai-Keen; Walker, David; Sellers, Laura Journal: European journal of surgical oncology Issue: Volume 42:Issue 11(2016:Nov.) Page Start: S251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors. Issue 7 (21st April 2020) Authors: Lord, Rosemary; Rauniyar, Jyoti; Morris, Tamsin; Condon, Orlaith; Jones, Rachel; Miller, Rowan; Hall, Marcia; Lofts, Fiona; Glasspool, Rosalind M; Hudson, Emma Journal: International journal of gynecological cancer Issue: Volume 30:Issue 7(2020) Page Start: 1026 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly‐ADP ribose polymerase inhibitors. Issue 7 (July 2020) Authors: Lord, Rosemary; Rauniyar, Jyoti; Morris, Tamsin; Condon, Orlaith; Jones, Rachel; Miller, Rowan; Hall, Marcia; Lofts, Fiona; Glasspool, Rosalind M; Hudson, Emma Journal: International journal of gynecological cancer Issue: Volume 30:Issue 7(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗